Navigation Links
Biostar Pharmaceuticals, Inc. Completes 8.6-Acre Land Purchase to House New Raw Materials Processing Plant
Date:3/10/2009

NEW YORK, March 10 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) today announced that it has acquired 8.6 acres of land located in Xi'an, thirty-five kilometers from the Company's operating facility in Xian Yang, China. The property cost was approximately $2.92 million (20,000,000 RMB). Biostar is planning for the construction of a 6,000 square meter pharmaceutical raw material processing plant on the land acquired. Construction is expected to begin in April of this year and should take approximately six months to complete and is currently budgeted at $2.3 million (16,000,000 RMB).

The acquisition of land was first started in October 2008 in conjunction with the lease of approximately 80 acres of farming land in the hillsides of the Qinling Mountains -- located approximately 5 kilometers from the acquired property. Rented from local farmers, the property is suitable to host a broad variety of the herbs and plants used in Biostar's pharmaceutical products. Together, these two transactions represent the first steps in the Company's 2009 expansion strategy.

In recent months the Company has hired approximately 60 regional farmers to manage the seasonal plantings of a number of plant breeds including salvia, honeysuckle, chrysanthemum, radix, walnuts, pepper, eucommia, shan yu, codonopsis, schisandra, ginseng, turmeric, radix gentianae macrophyllae, radix platycodnis, polygala, and angelica on the leased farmland. When harvested these plants will be processed in the new Xi'an facility, which is expected to be operational by year end and will result in approximately 50 new jobs for factory workers and salespeople. The Company anticipates that it will initially require approximately 25% of the harvested and processed herbal raw materials for its internal production and will sell the remaining inventory to regional wholesalers. These wholesalers have already been c
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
2. Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
3. Alseres Pharmaceuticals, Inc. Announces $200,000 Financing
4. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
5. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
6. Angiotech Pharmaceuticals, Inc. - Notice of conference call and webcast
7. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
8. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
9. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
10. Genesis Pharmaceuticals Enters Into Agreement to Purchase Hongrui Pharmaceuticals, and Acquire 22 New Traditional Chinese Medicines
11. Renhuang Pharmaceuticals, Inc. Engages New Independent Auditor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Three new interactive anatomy education apps from...pand health sciences learning opportunities for iP...ham, NC (Vocus) November 27, 2009 -- Modality, In... division of Wolters Kluwer Health, today announce...apps on the App Store. Clemente’s Anatomy, R...
(Date:11/26/2009)... too heavy can lead to strains or worse , ...y be nothing wrong with stuffing your turkey full ... thing with your suitcase as you pack for holiday ...n 2008 in U.S. hospital emergency rooms, doctors, ...luggage-related injuries, such as muscle strains, ...
(Date:11/26/2009)... Benton Communications announces a highly effectiv...tailers struggling to make an economic recovery. ...9 -- Flu fears is the type of challenge that could...according to Dr. David Benton, business growth exp...th system – The Rfactor Intensive . &ldqu...
(Date:11/25/2009)...,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleading...dsoftwareandCalgaryScientificInc.,aleadingprovider...ersionofAegis(TM)Breast4DAdvancedVisualizationsoft...zero-footprintWebclientbasedmedicalimagingoffering...allowsforzero-footprintaccess-requiringnosoftwared...
(Date:11/25/2009)...25/PRNewswire/--TheBayAreaAirQualityManagementDist...he Air Alert forThursday,November26,2009wh...olidfuel,bothindoorsandoutdoors. ,, "Cold,still...,"saidJackBroadbent,executiveofficeroftheAirDistri...ftheirneighborsandfellowcommunitymembersthisThanks...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...mission computed tomography (SPECT), researchers i...differences in the brains of individuals with gene...ial phobia), providing evidence of a long-suspecte...ments of the serotonin and dopamine neurotransmitt...
...ve end-of-life care for older people in the final ...review published in the May issue of Journal of Cl... with dementia from suffering from protracted, pot...oming a major international public health concern ...
...ot receiving the support they need to stop smoking...aths from cardiovascular and respiratory illnesses...iffith Universitys School of Medicine, health serv...ess disorder. , He said smoking rates in people ...
...d by Dr Ruth Kluck at Melbournes Walter and Eliza ... the mechanism by which cells destroy themselves. ...s cause the cell to self-destruct by puncturing it...for drugs designed to regulate cell death. , Dr ...
...stCall/ - AlphaRx (OTC BB:ALRX -,News), an emergin...drug,delivery technology to develop novel formulat...nical development of Indaflex(TM), its topical NSA..., Cypress acquired Proprius Pharmaceuticals, Inc.,...
...ll/ - Novadaq(R) Technologies Inc.,(TSX: NDQ), a d...ystems for,use in the operating room, today announ...March 31, 2008. In this press release, unless othe...2% increase in SPY consumable sales and 20% i...
Other Medicine News:Health News:Are anxiety disorders all in the mind? 2Health News:End-stage dementia patients deserve the same access to palliative care as people with cancer 2Health News:End-stage dementia patients deserve the same access to palliative care as people with cancer 3Health News:Quit smoking message not getting air time in mental health care 2Health News:Key step in the 'puncture' mechanism of cell death revealed 2Health News:AlphaRx's Indaflex(TM) Continues its Clinical Development 2Health News:Novadaq Reports Financial Results for the First Quarter of 2008 2Health News:Novadaq Reports Financial Results for the First Quarter of 2008 3Health News:Novadaq Reports Financial Results for the First Quarter of 2008 4Health News:Novadaq Reports Financial Results for the First Quarter of 2008 5Health News:Novadaq Reports Financial Results for the First Quarter of 2008 6Health News:Novadaq Reports Financial Results for the First Quarter of 2008 7Health News:Novadaq Reports Financial Results for the First Quarter of 2008 8Health News:Novadaq Reports Financial Results for the First Quarter of 2008 9Health News:Novadaq Reports Financial Results for the First Quarter of 2008 10Health News:Novadaq Reports Financial Results for the First Quarter of 2008 11
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.co...nitscatalogue: ,, PainManagement-GlobalTrends...n-Management---Global-Trends.html ,, Widesprea...entclinics,andtheadventofnewdrugshaveacceleratedth...eformsandreimbursementstructurecontinuetoshapedema...
(Date:11/25/2009)..., DELFT,TheNetherlandsandJOHANNESBURG,Novembe...visionandPyxisDiscoveryannouncedtoday,thattheyhave...ompanies,services. , Pyxis,sworldclasscomputa...pledwithiThemba,sservicedivisiontoprovidemedicinal...hroughPyxis,internationalclientnetwork.iThembaPha...
(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- C...icaldatafromtheCompany,sPROTECT-1(theProspectiveRa...)ofTraficet-EN(TM)(CCX282-B)inpatientswithmoderate...cywithafavorablesafetyandtolerabilityprofile.Thest...ctionofdiseaseseverityasdefinedasa70-pointdecrease...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Delaying Weight Loss Surgery May Leave Teens at Risk 58774 1Delaying Weight Loss Surgery May Leave Teens at Risk 58774 2Daily Dose of Vitamin D Helps Prevent Falls in Seniors 58770 1Daily Dose of Vitamin D Helps Prevent Falls in Seniors 58770 2Bionovo Announces Pricing of Securities Offering 58766 1Bionovo Announces Pricing of Securities Offering 58766 2Bionovo Announces Pricing of Securities Offering 58766 3
...idem tartrate sublingual lozenge) developed to be ...iddle of the night when patients awaken an...D, Calif., Oct. 1 Transcept Pharmaceuticals,Inc.,..., announced today,that it has submitted a New Drug...istration (FDA) for its lead product candidate, In...
...tics and genetic testing give women answers about ...ON, Ohio, Oct. 1 According to the U.S. Cancer,Sta... new cases of breast,cancer will be diagnosed in A...s are resulting in the earlier detection of the di...ted, breast cancer claimed the lives of,more than ...
Other Medicine Technology:Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 3Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 4
Maxi-Therm® Single-Patient Use
Maxi-Therm® Lite Single-Patient Use
Critical Care °CureWrap
... Besides pioneering read-through motion and low pe...troduce many other breakthrough designs, including...s contain an identifier that automatically tells t...ows clinicians to use sensors made specifically fo...
Medicine Products: